Literature DB >> 2216999

Raised dopamine metabolites in a case of malignant paraganglioma.

C M Florkowski1, D J Fairlamb, M G Freeth, S A Taylor, A Taylor, C Weinkove, A G Jacobs.   

Abstract

This paper describes the case of a malignant retroperitoneal paraganglioma with extensive metastases. The patient presented with a supraclavicular mass and an absence of hypertension. Exclusively raised dopamine metabolites were detected which may be a marker of a malignant process and account for the lack of hypertension.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2216999      PMCID: PMC2429596          DOI: 10.1136/pgmj.66.776.471

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  11 in total

1.  STUDIES OF FUNCTIONAL NEURAL TUMORS. VI. BIOCHEMICAL DIAGNOSIS.

Authors:  L R GJESSING
Journal:  Scand J Clin Lab Invest       Date:  1964       Impact factor: 1.713

2.  Malignant pheochromocytoma of the organs of Zuckerkandl.

Authors:  C ISAACSON; D ROSENZWEIG; H C SEFTEL
Journal:  Arch Pathol       Date:  1960-12

3.  Identification of hydroxytyramine in a chromaffin tumour.

Authors:  M MCMILLAN
Journal:  Lancet       Date:  1956-08-11       Impact factor: 79.321

4.  Adrenaline and noradrenaline; distribution and action.

Authors:  U S VON EULER
Journal:  Pharmacol Rev       Date:  1954-03       Impact factor: 25.468

5.  Determination of urinary 3-methoxy-4-hydroxymandelic and 3-methoxy-4-hydroxyphenylacetic acids by fused silica capillary gas chromatography.

Authors:  S Price; K Davenport; J D Berg
Journal:  Ann Clin Biochem       Date:  1986-05       Impact factor: 2.057

6.  Malignant chemodectoma of the superior mediastinum with elevated urinary homovanillic acid.

Authors:  R W Enquist; D C Tormey; E H Jenis; R L Warkel
Journal:  Chest       Date:  1974-08       Impact factor: 9.410

7.  Deficiency of dopamine-beta-hydroxylase. A new mechanism for normotensive pheochromocytomas.

Authors:  J M Feldman; J A Blalock; R T Zern; J D Shelburne; J T Gaede; R E Farrell; S A Wells
Journal:  Am J Clin Pathol       Date:  1979-08       Impact factor: 2.493

8.  A re-evaluation of dopamine excretion in phaeochromocytoma.

Authors:  P A Tippett; A J McEwan; D M Ackery
Journal:  Clin Endocrinol (Oxf)       Date:  1986-10       Impact factor: 3.478

9.  Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion.

Authors:  C Proye; P Fossati; P Fontaine; J Lefebvre; M Decoulx; J L Wemeau; D Dewailly; E Rwamasirabo; P Cecat
Journal:  Surgery       Date:  1986-12       Impact factor: 3.982

10.  Dopamine excretion in benign pheochromocytoma.

Authors:  P A Serrano; B Chavez-Lara; G Sanchez-Torres
Journal:  Biomedicine       Date:  1978-11
View more
  1 in total

1.  Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations.

Authors:  Kathryn S King; Tamara Prodanov; Vitaly Kantorovich; Tito Fojo; Jacqueline K Hewitt; Margaret Zacharin; Robert Wesley; Maya Lodish; Margarita Raygada; Anne-Paule Gimenez-Roqueplo; Shana McCormack; Graeme Eisenhofer; Dragana Milosevic; Electron Kebebew; Constantine A Stratakis; Karel Pacak
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.